Insilico Medicine

Insilico Medicine on fru.dev

Insilico Medicine across fru.dev: timeline

  1. Rentosertib trial data read out on six proteomic aging clocks (Emerging)
  2. Insilico Medicine: IPO $293M (Emerging)
  3. Nature Medicine publishes Phase 2a trial of AI-discovered drug rentosertib (Emerging)
  4. Insilico reports positive Phase 2a results for its AI-designed IPF drug (Emerging)

Sources